id	sid	eid	entity	type
bptjm-30	1	1	berkeley pharma tech journal	ORG
bptjm-30	1	2	mdd	ORG
bptjm-30	1	3	august 12	DATE
bptjm-30	1	4	2022	CARDINAL
bptjm-30	1	5	october 31	DATE
bptjm-30	1	6	2022	CARDINAL
bptjm-30	1	7	december 28	DATE
bptjm-30	1	8	2022	CARDINAL
bptjm-30	1	9	4.0	CARDINAL
bptjm-30	7	1	suhina sharma	PERSON
bptjm-30	7	2	matt gostkowski	PERSON
bptjm-30	7	3	jay patel	PERSON
bptjm-30	7	4	christina yang	PERSON
bptjm-30	7	5	21 1	DATE
bptjm-30	8	1	the last few years	DATE
bptjm-30	8	2	mdd	ORG
bptjm-30	9	1	the last year	DATE
bptjm-30	9	2	over 45,000	CARDINAL
bptjm-30	9	3	about one	CARDINAL
bptjm-30	9	4	every 11 minutes	TIME
bptjm-30	9	5	the united states1	LOC
bptjm-30	10	1	mdd	ORG
bptjm-30	10	2	daily	DATE
bptjm-30	11	1	inhibition2	PERSON
bptjm-30	12	1	depression3	PERSON
bptjm-30	16	1	option4	DATE
bptjm-30	16	2	option5	ORG
bptjm-30	16	3	drugs6	GPE
bptjm-30	16	4	depression8	PERSON
bptjm-30	21	1	berkeley pharma tech journal	ORG
bptjm-30	21	2	22 2	CARDINAL
bptjm-30	21	3	mdd	ORG
bptjm-30	22	1	one	CARDINAL
bptjm-30	22	2	disorder9	PERSON
bptjm-30	26	1	system9	ORG
bptjm-30	32	1	mdd	ORG
bptjm-30	32	2	abnormalities9	PERSON
bptjm-30	34	1	mdd	ORG
bptjm-30	34	2	mdd	ORG
bptjm-30	35	1	gaba	ORG
bptjm-30	36	1	berkeley pharma tech journal	ORG
bptjm-30	36	2	23	CARDINAL
bptjm-30	38	1	hypothesis9	PERSON
bptjm-30	39	1	mdd	ORG
bptjm-30	40	1	night11	GPE
bptjm-30	41	1	daytime	TIME
bptjm-30	43	1	rem	ORG
bptjm-30	43	2	mdd9	LAW
bptjm-30	45	1	3	CARDINAL
bptjm-30	45	2	decades	DATE
bptjm-30	46	1	5-ht1b	DATE
bptjm-30	46	2	projects12	NORP
bptjm-30	47	1	5-ht	QUANTITY
bptjm-30	48	1	5-ht	QUANTITY
bptjm-30	50	1	cognition14	PERSON
bptjm-30	51	1	berkeley pharma tech journal	ORG
bptjm-30	51	2	24	CARDINAL
bptjm-30	51	3	5	CARDINAL
bptjm-30	52	1	5-ht	QUANTITY
bptjm-30	52	2	receptors15	GPE
bptjm-30	53	1	5	CARDINAL
bptjm-30	54	1	5	CARDINAL
bptjm-30	55	1	5-ht	QUANTITY
bptjm-30	55	2	agents16	PRODUCT
bptjm-30	56	1	5	CARDINAL
bptjm-30	56	2	5	CARDINAL
bptjm-30	57	1	5-ht	QUANTITY
bptjm-30	57	2	mdd	ORG
bptjm-30	57	3	nmda	PERSON
bptjm-30	58	1	nmda	ORG
bptjm-30	59	1	nmda	ORG
bptjm-30	62	1	4	CARDINAL
bptjm-30	65	1	berkeley pharma tech journal	ORG
bptjm-30	65	2	25	CARDINAL
bptjm-30	68	1	5-ht2a	DATE
bptjm-30	68	2	activation22	PERSON
bptjm-30	69	1	5-ht2a	DATE
bptjm-30	69	2	functionality22	DATE
bptjm-30	73	1	berkeley pharma tech journal	ORG
bptjm-30	73	2	26	CARDINAL
bptjm-30	73	3	1	CARDINAL
bptjm-30	74	1	5	CARDINAL
bptjm-30	76	1	5-ht	QUANTITY
bptjm-30	76	2	5-ht	QUANTITY
bptjm-30	77	1	5-ht	QUANTITY
bptjm-30	77	2	5-ht	QUANTITY
bptjm-30	80	1	5-ht2a	CARDINAL
bptjm-30	84	1	berkeley pharma tech journal	ORG
bptjm-30	84	2	27	CARDINAL
bptjm-30	84	3	2	CARDINAL
bptjm-30	88	1	gaba	GPE
bptjm-30	88	2	interneuron	ORG
bptjm-30	90	1	berkeley pharma tech journal	ORG
bptjm-30	90	2	28	CARDINAL
bptjm-30	90	3	3	CARDINAL
bptjm-30	93	1	5	CARDINAL
bptjm-30	93	2	5.1	CARDINAL
bptjm-30	98	1	antidepressants27	GPE
bptjm-30	99	1	berkeley pharma tech journal	ORG
bptjm-30	99	2	29	CARDINAL
bptjm-30	100	1	processes28	PERSON
bptjm-30	101	1	metabolites29	ORG
bptjm-30	105	1	one	CARDINAL
bptjm-30	105	2	twenty-five	CARDINAL
bptjm-30	105	3	one	CARDINAL
bptjm-30	105	4	1	CARDINAL
bptjm-30	105	5	2 weeks	DATE
bptjm-30	105	6	1 month	DATE
bptjm-30	106	1	three	CARDINAL
bptjm-30	107	1	berkeley pharma tech journal	ORG
bptjm-30	107	2	30	CARDINAL
bptjm-30	107	3	hamilton	PERSON
bptjm-30	107	4	±	CARDINAL
bptjm-30	107	5	1	CARDINAL
bptjm-30	107	6	23.40 ± 5.38	MONEY
bptjm-30	107	7	1	CARDINAL
bptjm-30	107	8	21.20 ± 6.34	MONEY
bptjm-30	107	9	2	CARDINAL
bptjm-30	107	10	23.40 ± 5.38	MONEY
bptjm-30	107	11	2 weeks	DATE
bptjm-30	107	12	10.25 ± 6.40	MONEY
bptjm-30	107	13	3	CARDINAL
bptjm-30	107	14	23.40 ± 5.38	MONEY
bptjm-30	107	15	1 month	DATE
bptjm-30	107	16	10.45	CARDINAL
bptjm-30	107	17	1	CARDINAL
bptjm-30	107	18	hamilton	PERSON
bptjm-30	108	1	hamilton	PERSON
bptjm-30	108	2	patient31	ORG
bptjm-30	109	1	two-week	DATE
bptjm-30	110	1	one month	DATE
bptjm-30	112	1	5.2.	CARDINAL
bptjm-30	113	1	5-ht2a	DATE
bptjm-30	113	2	32	CARDINAL
bptjm-30	113	3	5	CARDINAL
bptjm-30	113	4	33	DATE
bptjm-30	114	1	berkeley pharma tech journal	ORG
bptjm-30	114	2	31	CARDINAL
bptjm-30	114	3	5ht2a	CARDINAL
bptjm-30	115	1	december 2016	DATE
bptjm-30	115	2	1 week	DATE
bptjm-30	115	3	up to 3 months	DATE
bptjm-30	115	4	12	CARDINAL
bptjm-30	116	1	6 month	DATE
bptjm-30	121	1	9month	ORDINAL
bptjm-30	121	2	56	CARDINAL
bptjm-30	121	3	two	CARDINAL
bptjm-30	122	1	berkeley pharma tech journal	ORG
bptjm-30	122	2	32	CARDINAL
bptjm-30	122	3	1	CARDINAL
bptjm-30	122	4	2 6 months	DATE
bptjm-30	122	5	hamd-17	DATE
bptjm-30	122	6	18.40	CARDINAL
bptjm-30	122	7	17.77	CARDINAL
bptjm-30	122	8	6.17	CARDINAL
bptjm-30	122	9	4.28 3.46	CARDINAL
bptjm-30	122	10	7.04	CARDINAL
bptjm-30	122	11	47.46	CARDINAL
bptjm-30	122	12	34.64	MONEY
bptjm-30	122	13	35.32	CARDINAL
bptjm-30	122	14	23.50	MONEY
bptjm-30	122	15	disturbancef	NORP
bptjm-30	122	16	41.76	CARDINAL
bptjm-30	122	17	33.74 26.08	CARDINAL
bptjm-30	122	18	23.50	MONEY
bptjm-30	122	19	16.48 14.35 mqol	QUANTITY
bptjm-30	122	20	5.69 6.17 6.90 6.88	QUANTITY
bptjm-30	122	21	5.32 7.14 7.46 7.65	QUANTITY
bptjm-30	122	22	6.03	CARDINAL
bptjm-30	122	23	5.43 7.23	QUANTITY
bptjm-30	122	24	7.62	CARDINAL
bptjm-30	122	25	13.56	CARDINAL
bptjm-30	122	26	14.15	CARDINAL
bptjm-30	122	27	17.16 17.43	CARDINAL
bptjm-30	122	28	2	CARDINAL
bptjm-30	123	1	10	CARDINAL
bptjm-30	123	2	1	CARDINAL
bptjm-30	123	3	2	DATE
bptjm-30	123	4	6month	CARDINAL
bptjm-30	123	5	two	CARDINAL
bptjm-30	141	1	hamd-17	DATE
bptjm-30	142	1	berkeley pharma tech journal	ORG
bptjm-30	142	2	33	CARDINAL
bptjm-30	146	1	mood34	PERSON
bptjm-30	147	1	distress34	PRODUCT
bptjm-30	150	1	optimism34	ORG
bptjm-30	151	1	psilocybin	PERSON
bptjm-30	152	1	psilocybin33,34	DATE
bptjm-30	153	1	neuroplasticity33	ORG
bptjm-30	154	1	november 2021	DATE
bptjm-30	154	2	dusp1)33,34	DATE
bptjm-30	155	1	10 percent33	DATE
bptjm-30	156	1	2021	CARDINAL
bptjm-30	156	2	brain33	ORG
bptjm-30	157	1	psilocybin	PERSON
bptjm-30	162	1	berkeley pharma tech journal	ORG
bptjm-30	162	2	34 5.3	CARDINAL
bptjm-30	166	1	cortex35	PERSON
bptjm-30	174	1	37	CARDINAL
bptjm-30	176	1	twenty-nine	CARDINAL
bptjm-30	178	1	at least seven days	DATE
bptjm-30	180	1	therapies35	NORP
bptjm-30	181	1	berkeley pharma tech journal	ORG
bptjm-30	181	2	35	CARDINAL
bptjm-30	186	1	depression41	GPE
bptjm-30	187	1	5-ht2a	DATE
bptjm-30	189	1	behaviors43	PRODUCT
bptjm-30	191	1	one	CARDINAL
bptjm-30	191	2	mtorc1	PERSON
bptjm-30	191	3	5	CARDINAL
bptjm-30	193	1	20	CARDINAL
bptjm-30	193	2	2 weeks	DATE
bptjm-30	195	1	mdd	ORG
bptjm-30	195	2	berkeley pharma tech journal	ORG
bptjm-30	195	3	36	CARDINAL
bptjm-30	195	4	5-ht2a	DATE
bptjm-30	197	1	mtorc1	PERSON
bptjm-30	198	1	the 1970s	DATE
bptjm-30	198	2	the past few decades46	DATE
bptjm-30	200	1	focus47	GPE
bptjm-30	201	1	5.4	CARDINAL
bptjm-30	202	1	functions7	GPE
bptjm-30	203	1	chinese	NORP
bptjm-30	203	2	compounds7	ORG
bptjm-30	206	1	multi-ways48	ORG
bptjm-30	208	1	berkeley pharma tech journal	ORG
bptjm-30	208	2	37	CARDINAL
bptjm-30	213	1	depression50	GPE
bptjm-30	216	1	depression50	ORG
bptjm-30	217	1	ttk	ORG
bptjm-30	217	2	new zealand	GPE
bptjm-30	218	1	ttk	ORG
bptjm-30	221	1	xiaoyaosan	PERSON
bptjm-30	221	2	rats52	GPE
bptjm-30	222	1	xiaoyaosan	PERSON
bptjm-30	223	1	tak1	PERSON
bptjm-30	223	2	irak1	PERSON
bptjm-30	225	1	berkeley pharma tech journal	ORG
bptjm-30	225	2	38	CARDINAL
bptjm-30	226	1	inadequate54	ORG
bptjm-30	230	1	5.5	CARDINAL
bptjm-30	230	2	four	CARDINAL
bptjm-30	231	1	signaling8	PERSON
bptjm-30	235	1	t4	ORG
bptjm-30	235	2	t3	ORG
bptjm-30	236	1	depression56	GPE
bptjm-30	239	1	mdd	ORG
bptjm-30	239	2	popularity58	GPE
bptjm-30	241	1	berkeley pharma tech journal	ORG
bptjm-30	241	2	39	CARDINAL
bptjm-30	242	1	body8	ORG
bptjm-30	245	1	three	CARDINAL
bptjm-30	246	1	3	CARDINAL
bptjm-30	247	1	berkeley pharma tech journal	ORG
bptjm-30	247	2	40 6	DATE
bptjm-30	255	1	7	CARDINAL
bptjm-30	256	1	5-ht2a	DATE
bptjm-30	259	1	berkeley pharma tech journal	ORG
bptjm-30	259	2	41 8	DATE
bptjm-30	260	1	recent years	DATE
bptjm-30	270	1	years	DATE
bptjm-30	273	1	berkeley pharma tech journal	ORG
bptjm-30	273	2	42	CARDINAL
bptjm-30	273	3	recent years	DATE
bptjm-30	276	1	berkeley pharma tech journal	ORG
bptjm-30	276	2	43	CARDINAL
bptjm-30	276	3	1	CARDINAL
bptjm-30	277	1	national institute of mental health	ORG
bptjm-30	279	1	july 24	DATE
bptjm-30	279	2	2022	CARDINAL
bptjm-30	280	1	2	CARDINAL
bptjm-30	280	2	penn e	PERSON
bptjm-30	280	3	tracy dk	PERSON
bptjm-30	283	1	adv psychopharmacol	ORG
bptjm-30	284	1	2012;2(5):179-188	CARDINAL
bptjm-30	285	1	3	CARDINAL
bptjm-30	285	2	al-harbi ks	PERSON
bptjm-30	287	1	4	CARDINAL
bptjm-30	288	1	szarmach	PERSON
bptjm-30	288	2	cubała wj	PERSON
bptjm-30	291	1	5	CARDINAL
bptjm-30	291	2	johnson mw	PERSON
bptjm-30	291	3	griffiths rr	PERSON
bptjm-30	293	1	neurotherapeutics	PERSON
bptjm-30	294	1	2017;14(3):734-740	CARDINAL
bptjm-30	295	1	017-0542	CARDINAL
bptjm-30	295	2	6	CARDINAL
bptjm-30	296	1	johnson mw	PERSON
bptjm-30	298	1	2015;187(14):1054-1059	CARDINAL
bptjm-30	299	1	7	CARDINAL
bptjm-30	299	2	d.	NORP
bptjm-30	300	1	gynecol clin north am	PERSON
bptjm-30	302	1	joffe rt	PERSON
bptjm-30	303	1	dialogues clin neurosci	PERSON
bptjm-30	304	1	2011;13(1):127	CARDINAL
bptjm-30	305	1	9	CARDINAL
bptjm-30	308	1	2010;9(3):155-161	CARDINAL
bptjm-30	310	1	shen	ORG
bptjm-30	310	2	sahir n.	PERSON
bptjm-30	313	1	2011;16(4):383-406	CARDINAL
bptjm-30	314	1	doi:10.1038	ORG
bptjm-30	314	2	11	CARDINAL
bptjm-30	315	1	national institute of general medical sciences	ORG
bptjm-30	318	1	september 9, 2021	DATE
bptjm-30	319	1	20mental 12	CARDINAL
bptjm-30	320	1	nautiyal km	PERSON
bptjm-30	320	2	r.	NORP
bptjm-30	321	1	2017;6:123	DATE
bptjm-30	322	1	f1000research.9736.1 13	DATE
bptjm-30	323	1	garcia-garcia al	PERSON
bptjm-30	323	2	newman	PERSON
bptjm-30	323	3	leonardo ed.	PERSON
bptjm-30	326	1	2013;231(4):623	CARDINAL
bptjm-30	326	2	636	CARDINAL
bptjm-30	326	3	14	CARDINAL
bptjm-30	329	1	2016	DATE
bptjm-30	330	1	34/ 15	DATE
bptjm-30	331	1	jenkins t	PERSON
bptjm-30	331	2	nguyen j	PERSON
bptjm-30	331	3	polglaze k	PERSON
bptjm-30	331	4	https://www.nigms.nih.gov/education/fact-sheets/pages/circadian-rhythms.aspx#:~:text=circadian%20rhythms%20are%20physical%2c%20mental	NORP
bptjm-30	331	5	berkeley pharma tech journal	ORG
bptjm-30	331	6	44	DATE
bptjm-30	333	1	2016;8(1):56	CARDINAL
bptjm-30	334	1	dale e	PERSON
bptjm-30	334	2	pehrson al	PERSON
bptjm-30	336	1	2015;21(2):143-161	CARDINAL
bptjm-30	337	1	17	CARDINAL
bptjm-30	337	2	niciu mj	PERSON
bptjm-30	338	1	annual	DATE
bptjm-30	339	1	2014;54(1):119-139	CARDINAL
bptjm-30	340	1	annurevpharmtox-011613-135950 18	DATE
bptjm-30	341	1	nmda	ORG
bptjm-30	343	1	2012;4(6):a005710	CARDINAL
bptjm-30	344	1	2012	DATE
bptjm-30	344	2	1	CARDINAL
bptjm-30	344	3	19	CARDINAL
bptjm-30	344	4	j. ampa	PERSON
bptjm-30	345	1	cns &	ORG
bptjm-30	347	1	20	CARDINAL
bptjm-30	348	1	braund ta	PERSON
bptjm-30	348	2	tillman g	PERSON
bptjm-30	348	3	palmer dm	PERSON
bptjm-30	348	4	gordon e	PERSON
bptjm-30	348	5	aj	PERSON
bptjm-30	348	6	harris	PERSON
bptjm-30	350	1	2021;11(1	CARDINAL
bptjm-30	351	1	doi:10.1038	ORG
bptjm-30	354	1	2008;10(4):385-400	CARDINAL
bptjm-30	355	1	22	CARDINAL
bptjm-30	356	1	murnane ks	PERSON
bptjm-30	356	2	2a	CARDINAL
bptjm-30	358	1	2019;30:151-162	CARDINAL
bptjm-30	359	1	fbp.000000000000045 23	CARDINAL
bptjm-30	360	1	hasselmann h. ketamine	PERSON
bptjm-30	363	1	2014;12(1):57-70	CARDINAL
bptjm-30	364	1	24	CARDINAL
bptjm-30	367	1	2017;87:9-12	CARDINAL
bptjm-30	368	1	doi:10.1016/j.curtheres.2017.07.001	GPE
bptjm-30	368	2	25	DATE
bptjm-30	369	1	jw	PERSON
bptjm-30	369	2	farber nb	PERSON
bptjm-30	369	3	olney jw	PERSON
bptjm-30	369	4	nmda	ORG
bptjm-30	370	1	clin neurosci	PERSON
bptjm-30	371	1	2000;2(3):219232	CARDINAL
bptjm-30	372	1	26	CARDINAL
bptjm-30	373	1	aleksandrova lr	PERSON
bptjm-30	373	2	phillips ag	ORG
bptjm-30	373	3	wang yt.	ORG
bptjm-30	374	1	j psychiatry neurosci	PERSON
bptjm-30	375	1	2017;42(4):222-229	CARDINAL
bptjm-30	378	1	kowalczyk m	PERSON
bptjm-30	378	2	kowalczyk e	GPE
bptjm-30	378	3	kwiatkowski p	PERSON
bptjm-30	378	4	ł	ORG
bptjm-30	378	5	m. ketamine-new	PERSON
bptjm-30	380	1	2021;11(11):1186	CARDINAL
bptjm-30	380	2	2021	CARDINAL
bptjm-30	380	3	nov 5	DATE
bptjm-30	381	1	d'sa c	PERSON
bptjm-30	381	2	duman rs	PERSON
bptjm-30	382	1	disord	ORG
bptjm-30	383	1	2002;4(3):183-194	CARDINAL
bptjm-30	383	2	29	CARDINAL
bptjm-30	384	1	dimitrov iv	PERSON
bptjm-30	384	2	harvey mg	PERSON
bptjm-30	384	3	voss lj	PERSON
bptjm-30	384	4	sleigh berkeley pharma tech journal	ORG
bptjm-30	384	5	45	CARDINAL
bptjm-30	384	6	bickerdike mj	PERSON
bptjm-30	384	7	denny wa	PERSON
bptjm-30	386	1	2020;25(12):2950	CARDINAL
bptjm-30	386	2	2020	DATE
bptjm-30	386	3	jun 26	PERSON
bptjm-30	388	1	mm	PERSON
bptjm-30	388	2	tyagi	NORP
bptjm-30	388	3	cortés p	PERSON
bptjm-30	388	4	nitrergic rheb degradation	ORG
bptjm-30	390	1	2016;21(3):313-319	CARDINAL
bptjm-30	391	1	doi:10.1038	ORG
bptjm-30	392	1	31	CARDINAL
bptjm-30	393	1	mandal s	PERSON
bptjm-30	394	1	indian	NORP
bptjm-30	395	1	2019;61(5):480-485	CARDINAL
bptjm-30	395	2	8 32	DATE
bptjm-30	396	1	davis ak	PERSON
bptjm-30	396	2	barsuglia jp	PERSON
bptjm-30	396	3	griffiths rr	PERSON
bptjm-30	397	1	5	CARDINAL
bptjm-30	397	2	5	CARDINAL
bptjm-30	398	1	the american journal of drug and alcohol	ORG
bptjm-30	400	1	33	DATE
bptjm-30	401	1	korsakova l	ORG
bptjm-30	403	1	2021;14(12):1213	CARDINAL
bptjm-30	404	1	griffiths rr	PERSON
bptjm-30	404	2	johnson mw	PERSON
bptjm-30	404	3	carducci ma	PERSON
bptjm-30	406	1	2016;30(12):1181-1197	CARDINAL
bptjm-30	408	1	35	CARDINAL
bptjm-30	412	1	2018;49(4):655-663	CARDINAL
bptjm-30	413	1	36	CARDINAL
bptjm-30	414	1	hamilton jp	PERSON
bptjm-30	416	1	2015;78(4):224-230	CARDINAL
bptjm-30	416	2	doi:10.1016/j.biopsych.2015.02.020 37	ORG
bptjm-30	417	1	jiménez-garrido df	PERSON
bptjm-30	417	2	gómez-sousa m	PERSON
bptjm-30	417	3	ona g	PERSON
bptjm-30	419	1	2020;10(1	ORG
bptjm-30	420	1	doi:10.1038	ORG
bptjm-30	420	2	38	CARDINAL
bptjm-30	421	1	szilágyi	PERSON
bptjm-30	424	1	2022;10(5):997	CARDINAL
bptjm-30	425	1	2022	CARDINAL
bptjm-30	425	2	26	CARDINAL
bptjm-30	427	1	davis ak	PERSON
bptjm-30	427	2	averill la	ORG
bptjm-30	427	3	barsuglia jp	PERSON
bptjm-30	429	1	2020;4:247054702093956	TIME
bptjm-30	430	1	40	CARDINAL
bptjm-30	431	1	loizaga-velder	PERSON
bptjm-30	433	1	2014;46(1):63-72	DATE
bptjm-30	434	1	doi:10.1080/02791072.2013.873157 41	DATE
bptjm-30	436	1	greb ac	PERSON
bptjm-30	436	2	cameron lp	PERSON
bptjm-30	437	1	berkeley pharma tech journal	ORG
bptjm-30	437	2	46	CARDINAL
bptjm-30	439	1	2018;23(11):31703182	CARDINAL
bptjm-30	439	2	doi:10.1016	GPE
bptjm-30	439	3	42	CARDINAL
bptjm-30	440	1	fuentes jj	PERSON
bptjm-30	440	2	torrens m.	PERSON
bptjm-30	442	1	2020;10	CARDINAL
bptjm-30	443	1	doi:10.3389	ORG
bptjm-30	443	2	43	CARDINAL
bptjm-30	444	1	mueller f	PERSON
bptjm-30	444	2	lenz	PERSON
bptjm-30	446	1	2017;7(4):e1084	CARDINAL
bptjm-30	446	2	doi:10.1038	ORG
bptjm-30	447	1	hendricks ps	PERSON
bptjm-30	447	2	thorne cb	PERSON
bptjm-30	447	3	clark cb	PERSON
bptjm-30	447	4	coombs dw	ORG
bptjm-30	447	5	johnson mw	PERSON
bptjm-30	447	6	the united states	GPE
bptjm-30	449	1	2015;29(3):280	CARDINAL
bptjm-30	450	1	45	CARDINAL
bptjm-30	450	2	gregorio dd	PERSON
bptjm-30	450	3	mtorc1	PERSON
bptjm-30	451	1	the national academy of sciences	ORG
bptjm-30	452	1	2021;118(5	CARDINAL
bptjm-30	453	1	46	CARDINAL
bptjm-30	454	1	carhart-harris	PERSON
bptjm-30	454	2	kaelen m	PERSON
bptjm-30	454	3	bolstridge m	PERSON
bptjm-30	457	1	2016;46(7):1379-1390	CARDINAL
bptjm-30	458	1	47	CARDINAL
bptjm-30	462	1	2017;42(11):2114-2127	DATE
bptjm-30	463	1	doi:10.1038	ORG
bptjm-30	464	1	dai w	ORG
bptjm-30	464	2	feng k	PERSON
bptjm-30	464	3	sun x	PERSON
bptjm-30	466	1	doi:10.1016	GPE
bptjm-30	466	2	49	CARDINAL
bptjm-30	467	1	noori t	PERSON
bptjm-30	467	2	sobarzo-sánchez e	GPE
bptjm-30	467	3	shirooie s.	PERSON
bptjm-30	469	1	curr neuropharmacol	PERSON
bptjm-30	470	1	2022;20(5):929-949	CARDINAL
bptjm-30	471	1	doi:10.2174/1570159x20666220103140834 50	DATE
bptjm-30	472	1	rajkowska g	PERSON
bptjm-30	472	2	miguel-hidalgo	PERSON
bptjm-30	472	3	j. gliogenesis	PERSON
bptjm-30	473	1	cns &	ORG
bptjm-30	474	1	2007;6(3):219-233	CARDINAL
bptjm-30	476	1	51	CARDINAL
bptjm-30	477	1	new zealand	GPE
bptjm-30	478	1	52	DATE
bptjm-30	479	1	ma k	PERSON
bptjm-30	479	2	mao f. natural	PERSON
bptjm-30	481	1	2022;2022	CARDINAL
bptjm-30	483	1	53	CARDINAL
bptjm-30	484	1	felger jc	PERSON
bptjm-30	484	2	lotrich fe	ORG
bptjm-30	486	1	2013;246:199-229	CARDINAL
bptjm-30	487	1	doi:10.1016	NORP
bptjm-30	487	2	54	CARDINAL
bptjm-30	488	1	cleveland clinic	ORG
bptjm-30	489	1	cleveland clinic	ORG
bptjm-30	490	1	cleveland clinic	ORG
bptjm-30	491	1	2013	DATE
bptjm-30	492	1	berkeley pharma tech journal	ORG
bptjm-30	492	2	47 55	DATE
bptjm-30	493	1	hara j	PERSON
bptjm-30	493	2	sakurai t	PERSON
bptjm-30	493	3	xie x	PERSON
bptjm-30	493	4	kilduff	PERSON
bptjm-30	496	1	2009;29(12):3705-3714	DATE
bptjm-30	499	1	shahid ma	PERSON
bptjm-30	499	2	sandeep sharma	PERSON
bptjm-30	502	1	march 23, 2019	DATE
bptjm-30	503	1	57	CARDINAL
bptjm-30	504	1	mcewen bs	PERSON
bptjm-30	504	2	akama kt	PERSON
bptjm-30	504	3	spencer-segal	PERSON
bptjm-30	507	1	2012;126(1):4-16	CARDINAL
bptjm-30	508	1	58	CARDINAL
bptjm-30	509	1	tonon ac	ORG
bptjm-30	509	2	pilz lk	PERSON
bptjm-30	509	3	markus rp	PERSON
bptjm-30	509	4	hidalgo mp	PERSON
bptjm-30	509	5	elisabetsky e. melatonin	PERSON
bptjm-30	511	1	2021;12	CARDINAL
bptjm-30	511	2	29	CARDINAL
bptjm-30	512	1	sharma et al	PERSON
bptjm-30	513	1	2	CARDINAL
bptjm-30	513	2	4	CARDINAL
bptjm-30	513	3	5.1	CARDINAL
bptjm-30	514	1	5.2	CARDINAL
bptjm-30	515	1	5.3	CARDINAL
bptjm-30	518	1	5.5	CARDINAL
bptjm-30	519	1	6	CARDINAL
bptjm-30	519	2	7	CARDINAL
bptjm-30	519	3	8	CARDINAL
bptjm-30	520	1	al	PERSON